Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion

被引:61
作者
Björklund, M
Heikkilä, P
Koivunen, E
机构
[1] Viikki Bioctr, Dept Biol & Environm Sci, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Inst Dent, FIN-00014 Helsinki, Finland
关键词
D O I
10.1074/jbc.M401601200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Migration of invasive cells appears to be dependent on matrix metalloproteinases (MMPs) anchored on the cell surface through integrins. We have previously demonstrated an interaction between the integrin alpha-subunit I domain and the catalytic domain of MMP-9. We now show that there is also an interaction between the integrin beta subunit and MMP-9. Using phage display, we have developed MMP-9 inhibitors that bind either to the MMP-9 catalytic domain, the collagen binding domain, or the C-terminal hemopexin-like domain. The C-terminal domain-binding peptide mimics an activation epitope in the stalk of the integrin beta chain and inhibits the association of MMP-9 C-terminal domain with alpha(V)beta(5) integrin. Unlike other MMP-9 binding peptides, it does not directly inhibit catalytic activity of MMP-9, but still prevents proenzyme activation and cell migration in vitro and tumor xenograft growth in vivo. We also find an association between MMP-9 and urokinase-plasminogen activator receptor and find that urokinase-plasminogen activator receptor is cleaved by MMP-9. Collectively, we have defined molecular details for several interactions mediated by the different MMP-9 domains.
引用
收藏
页码:29589 / 29597
页数:9
相关论文
共 48 条
  • [11] Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires β1 integrin engagement
    Festuccia, C
    Angelucci, A
    Gravina, GL
    Eleuterio, E
    Vicentini, C
    Bologna, M
    [J]. EXPERIMENTAL CELL RESEARCH, 2002, 280 (01) : 1 - 11
  • [12] Filardo EJ, 1996, J CELL SCI, V109, P1615
  • [13] Cell surface association of matrix metalloproteinase-9 (gelatinase B)
    Fridman, R
    Toth, M
    Chvyrkova, I
    Meroueh, SO
    Mobashery, S
    [J]. CANCER AND METASTASIS REVIEWS, 2003, 22 (2-3) : 153 - 166
  • [14] DEFINITION OF 2 ANGIOGENIC PATHWAYS BY DISTINCT ALPHA(V) INTEGRINS
    FRIEDLANDER, M
    BROOKS, PC
    SHAFFER, RW
    KINCAID, CM
    VARNER, JA
    CHERESH, DA
    [J]. SCIENCE, 1995, 270 (5241) : 1500 - 1502
  • [15] Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling
    Ghiso, JAA
    Kovalski, K
    Ossowski, L
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 147 (01) : 89 - 103
  • [16] Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells
    Ginestra, A
    Monea, S
    Seghezzi, G
    Dolo, V
    Nagase, H
    Mignatti, P
    Vittorelli, ML
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) : 17216 - 17222
  • [17] Biopanning and rapid analysis of selective interactive ligands
    Giordano, RJ
    Cardó-Vila, M
    Lahdenranta, J
    Pasqualini, R
    Arap, W
    [J]. NATURE MEDICINE, 2001, 7 (11) : 1249 - 1253
  • [18] Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
    Hamano, Y
    Zeisberg, M
    Sugimoto, H
    Lively, JC
    Maeshima, Y
    Yang, CQ
    Hynes, RO
    Werb, Z
    Sudhakar, A
    Kalluri, R
    [J]. CANCER CELL, 2003, 3 (06) : 589 - 601
  • [19] Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay
    Kim, J
    Yu, W
    Kovalski, K
    Ossowski, L
    [J]. CELL, 1998, 94 (03) : 353 - 362
  • [20] Tumor targeting with a selective gelatinase inhibitor
    Koivunen, E
    Arap, W
    Valtanen, H
    Rainisalo, A
    Medina, OP
    Heikkilä, P
    Kantor, C
    Gahmberg, CG
    Salo, T
    Konttinen, YT
    Sorsa, T
    Ruoslahti, E
    Pasqualini, R
    [J]. NATURE BIOTECHNOLOGY, 1999, 17 (08) : 768 - 774